- Home
- BATL vs SLGL Comparison
BATL vs SLGL Comparison
Compare BATL & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- SLGL
- Stock Information
- Founded
- BATL 1987
- SLGL 1997
- Country
- BATL United States
- SLGL Israel
- Employees
- BATL N/A
- SLGL N/A
- Industry
- BATL Oil & Gas Production
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- BATL Energy
- SLGL Health Care
- Exchange
- BATL Nasdaq
- SLGL Nasdaq
- Market Cap
- BATL 28.8M
- SLGL 30.9M
- IPO Year
- BATL N/A
- SLGL 2018
- Fundamental
- Price
- BATL $1.94
- SLGL $1.05
- Analyst Decision
- BATL
- SLGL Strong Buy
- Analyst Count
- BATL 0
- SLGL 2
- Target Price
- BATL N/A
- SLGL $5.00
- AVG Volume (30 Days)
- BATL 264.4K
- SLGL 1.5M
- Earning Date
- BATL 11-12-2024
- SLGL 03-12-2025
- Dividend Yield
- BATL N/A
- SLGL N/A
- EPS Growth
- BATL N/A
- SLGL N/A
- EPS
- BATL N/A
- SLGL N/A
- Revenue
- BATL $191,482,000.00
- SLGL $11,707,000.00
- Revenue This Year
- BATL $2.21
- SLGL $500.51
- Revenue Next Year
- BATL N/A
- SLGL N/A
- P/E Ratio
- BATL N/A
- SLGL N/A
- Revenue Growth
- BATL N/A
- SLGL 869.93
- 52 Week Low
- BATL $1.31
- SLGL $0.33
- 52 Week High
- BATL $9.66
- SLGL $1.65
- Technical
- Relative Strength Index (RSI)
- BATL 38.92
- SLGL 52.10
- Support Level
- BATL $1.76
- SLGL $1.11
- Resistance Level
- BATL $2.32
- SLGL $1.40
- Average True Range (ATR)
- BATL 0.20
- SLGL 0.21
- MACD
- BATL 0.12
- SLGL -0.01
- Stochastic Oscillator
- BATL 45.71
- SLGL 21.05
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.